Marksans Pharma fundamental analysis
MARKSANS
168.06
7.00 (4.35%)Last updated on 1 Feb, 2026 | 15:52 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Marksans Pharma Fundamentals
P/E Ratio
21.06
P/B Ratio
2.76
Div. Yield
0.49
Sector P/E
65.25
Sector P/B
1.2
Sec. Div. Yield
0.58
Marksans Pharma Fundamentals is currently trading with a P/E Ratio of 21.06, compared to the sector average of 65.25. Its P/B Ratio stands at 2.76, while the sector’s is 1.2. In terms of returns, the stock offers a Dividend Yield of 0.49%, which is than the sector’s 0.58%.
Marksans Pharma Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Marksans Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
